Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies
Identifying patients at different risk of relapse in childhood acute lymphoblastic leukemia (ALL)
Diffuse large B-cell lymphoma lymphoma: Finding the best partner for durvalumab
Potential second-line treatment for indolent lymphoma
Treatment at first relapse in multiple myeloma: how to choose a drug?